thiotepa has been researched along with Hormone-Dependent Neoplasms in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pegram, M | 1 |
Hsu, S | 1 |
Lewis, G | 1 |
Pietras, R | 1 |
Beryt, M | 1 |
Sliwkowski, M | 1 |
Coombs, D | 1 |
Baly, D | 1 |
Kabbinavar, F | 1 |
Slamon, D | 1 |
Elias, AD | 1 |
Ibrahim, J | 1 |
Richardson, P | 1 |
Avigan, D | 1 |
Joyce, R | 1 |
Reich, E | 1 |
McCauley, M | 1 |
Wheeler, C | 1 |
Frei, E | 1 |
1 trial available for thiotepa and Hormone-Dependent Neoplasms
Article | Year |
---|---|
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farbe
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma; Com | 2002 |
1 other study available for thiotepa and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal | 1999 |